0001662774 2026-06-26 2026-06-26 true 0001662774 8-K/A 2026-06-26 QUINCE THERAPEUTICS, INC. DE 001-38890 90-1024039 611 Gateway Boulevard Suite 273 South San Francisco CA 94080 (415) 910-5717 false false false false Common Stock, par value $0.001 per share QNCX NASDAQ false This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2026 (the “Original Form 8-K”) by Quince Therapeutics, Inc. The sole purpose of this Amendment is to correct the description of the reverse stock split described in Item 3.03 of the Original Form 8-K. This Current Report on Form 8-K/A hereby amends and restates in its entirety Item 3.03 of the Original Form 8-K to correct the error. The Original Form 8-K otherwise remains unchanged.